TABLE 1.
Administration | PK parameter | U | Value | SD | CV (%) |
---|---|---|---|---|---|
p.o., 5 mg/kg | Tmax | h | 0.833 | 1.01 | 121 |
Cmax | ng/ml | 151 | 82.5 | 54.6 | |
AUClast | h · ng/ml | 586 | 422 | 72.1 | |
AUCINF | h · ng/ml | 847 | NA | NA | |
Terminal t1/2 | h | 1.45 | NA | NA | |
F | % | 31.5 | 22.6 | 71.8 | |
i.v., 5 mg/kg | AUClast | h · ng/ml | 1874 | 263 | 14.01 |
AUCINF | h · ng/ml | 1909 | 279 | 14.62 | |
Terminal t1/2 | h | 1.41 | 0.13 | 9.27 | |
Vss | Liters/kg | 4.64 | 0.21 | 4.48 | |
CL | Liters/h/kg | 2.66 | 0.39 | 14.74 | |
MRT | h | 1.77 | 0.18 | 10.32 |
NA, not available (the PK parameter was not reported because the terminal phase could not be precisely determined). CV, coefficient of variation; p.o., peroral; i.v., intravenous. n = 3/time point.